WHO ICTRP trial
A RANDOMISED, MULTI-CENTRE, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED, 5-WAY…
EUCTR2007-006538-33-NL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2007-006538-33-NL |
|---|---|
| Public title | A RANDOMISED, MULTI-CENTRE, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED, 5-WAY, PARALLEL GROUP STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF ONO-8539 IN PATIENTS WITH OVERACTIVE BLADDER |
| Scientific title | A RANDOMISED, MULTI-CENTRE, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED, 5-WAY, PARALLEL GROUP STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF ONO-8539 IN PATIENTS WITH OVERACTIVE BLADDER |
| Primary sponsor | Ono Pharmaceutical Co. Ltd. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Hungary;Czech Republic;Netherlands;Sweden |
| Conditions | Overactive bladder MedDRA version: 9.1 Level: LLT Classification code 10059617 Term: Overactive bladder |
| Interventions | Product Name: ONO-8539 Tablets Product Code: ONO-8539 Pharmaceutical Form: Film-coated tablet INN or Proposed INN: 4-[({6-[Isobutyl(1,3-thiazol-2-ylsulfonyl)amino]- 2,3-dihydro-1H-inden-5-yl}oxy)methyl]- 3-methylbenzoic acid CAS Number… |
| Registration date | Sep 12, 2008 |
| Target size | 400 |
| Secondary IDs | ONO-8539POE004 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: